CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Operating Activities
Net earnings	$ 501,345	$ 509,796
Loss on assets held for sale	0	46,946
Adjustments to reconcile net earnings to cash from operating activities:
Depreciation and amortization	205,844	202,294
Share-based compensation expense	15,591	24,493
Gain on sale of businesses	(5,213)	0
Other, net	(7,731)	(6,107)
Cash effect of changes in assets and liabilities (excluding effects of acquisitions, dispositions and foreign exchange):
Accounts receivable, net	31,631	(67,603)
Inventories	(19,360)	(74,412)
Prepaid expenses and other assets	(24,198)	(29,336)
Accounts payable	(92,071)	(3,875)
Accrued compensation and employee benefits	(13,136)	(5,908)
Accrued expenses and other liabilities	118,779	(3,833)
Accrued and deferred taxes, net	(24,562)	(8,357)
Net cash provided by operating activities	686,919	584,098
Investing Activities
Additions to property, plant and equipment	(123,564)	(137,276)
Acquisitions, net of cash acquired	(258,674)	(215,687)
Proceeds from sale of property, plant, and equipment	5,090	2,838
Proceeds from sale of businesses	15,400	24,218
Other	(1,250)	(10,150)
Net cash (used in) provided by investing activities	(362,998)	(336,057)
Financing Activities
Repurchase of common stock, including prepayment under an accelerated share repurchase program	(52,916)	(23,280)
Change in commercial paper and notes payable	5,811	(37,650)
Dividends paid to stockholders	(213,028)	(211,072)
Payments to settle employee tax obligations on exercise of share-based awards	(21,450)	(29,011)
Other	(1,753)	(1,417)
Net cash used in by financing activities	(283,336)	(302,430)
Effect of Exchange Rate on Cash and Cash Equivalents	(10,337)	(1,300)
Net (decrease) increase in cash and cash equivalents	30,248	(55,689)
Cash and cash equivalents at beginning of period	397,253	396,221
Cash and cash equivalents at end of period	$ 427,501	$ 340,532